TY  - GEN
AU  - Buter,J
AU  - Janssen,R A
AU  - Martens,A
AU  - Sleijfer,D T
AU  - de Leij,L
AU  - Mulder,N H
TI  - Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer
SN  - 0959-8049
PY  - 1994///0308
KW  - Adult
KW  - Aged
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Injections, Subcutaneous
KW  - Interleukin-2
KW  - administration & dosage
KW  - Kidney Neoplasms
KW  - pathology
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Muromonab-CD3
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1016/0959-8049(93)90044-g
ER  -